Bisheng Zhu - Nanjing Medlander Deputy Manager
| 688273 Stock | 25.66 0.54 2.15% |
Executive
Bisheng Zhu is Deputy Manager of Nanjing Medlander Medical
| Age | 36 |
| Address | Building 5, Nanjing, China, 211100 |
| Phone | 86 25 5771 9209 |
| Web | https://www.medlander.com |
Nanjing Medlander Management Efficiency
The company has return on total asset (ROA) of 0.0386 % which means that it generated a profit of $0.0386 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0776 %, meaning that it generated $0.0776 on every $100 dollars invested by stockholders. Nanjing Medlander's management efficiency ratios could be used to measure how well Nanjing Medlander manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Non Currrent Assets Other is expected to grow to about 28.8 M, whereas Total Assets are forecasted to decline to about 1.1 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Wang Lei | Zhongshan Public Utilities | 39 | |
| Kewen Liu | Lander Sports Development | 38 | |
| Jin Li | Xiangyu Medical Co | 31 | |
| Kewen CPA | Lander Sports Development | 38 | |
| Zhang Jie | Xiangyu Medical Co | 39 | |
| Zuoqin Wei | Xiangyu Medical Co | 46 | |
| Hong Tian | Lander Sports Development | 56 | |
| Jing Liu | Xiangyu Medical Co | 40 | |
| Xuetao Liu | Zhongshan Public Utilities | 59 | |
| Tao Qiu | Lander Sports Development | N/A | |
| Wei Zou | Lander Sports Development | 43 | |
| Hong Cao | Sichuan Fulin Transportation | 43 | |
| Hui Cao | Zhongshan Public Utilities | 54 | |
| Weiguo Zhao | Sichuan Fulin Transportation | 35 | |
| Qing He | Zhongshan Public Utilities | N/A | |
| Ding Lin | Ningbo David Medical | 51 | |
| Mingyuan Li | Sichuan Fulin Transportation | 43 | |
Management Performance
| Return On Equity | 0.0776 | ||||
| Return On Asset | 0.0386 |
Nanjing Medlander Medical Leadership Team
Elected by the shareholders, the Nanjing Medlander's board of directors comprises two types of representatives: Nanjing Medlander inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanjing. The board's role is to monitor Nanjing Medlander's management team and ensure that shareholders' interests are well served. Nanjing Medlander's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanjing Medlander's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wang Wang, Deputy Manager | ||
| Ruijia Yang, Chairman Manager | ||
| Bin Chen, Director Manager | ||
| Ning Xu, Financial Director | ||
| Bisheng Zhu, Deputy Manager | ||
| Zhihuai Shi, Deputy Director | ||
| Honglin Tu, Deputy Manager | ||
| Jiangning Chen, Deputy Secretary |
Nanjing Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nanjing Medlander a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0776 | ||||
| Return On Asset | 0.0386 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 1.61 B | ||||
| Shares Outstanding | 100 M | ||||
| Shares Owned By Insiders | 69.35 % | ||||
| Shares Owned By Institutions | 8.60 % | ||||
| Price To Book | 1.92 X | ||||
| Price To Sales | 6.74 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Nanjing Stock
Nanjing Medlander financial ratios help investors to determine whether Nanjing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanjing with respect to the benefits of owning Nanjing Medlander security.